ANI Pharma Buys 31 Generic Drug Products from Teva for $12.5M in Cash, Percent of Future Gross Profits from Sales

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ), an emerging generic pharmaceutical company, today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals (NASDAQ: TEVA ) for $12.5 million in cash and a percentage of future gross profits from product sales. The acquisition includes 20 solid-oral immediate release products, 4